{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:42:40Z","timestamp":1762612960539,"version":"build-2065373602"},"reference-count":473,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443346415"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.apar.2025.09.001","type":"book-chapter","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:23:13Z","timestamp":1759789393000},"page":"1-82","source":"Crossref","is-referenced-by-count":0,"title":["Survival of the fittest: How Leishmania evades drug therapy"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.apar.2025.09.001_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13104-020-04973-y","article-title":"Relationship of Leishmania RNA Virus (LRV) and treatment failure in clinical isolates of Leishmania major","volume":"13","author":"Abtahi","year":"2020","journal-title":"BMC Res. Notes"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/jiv354","article-title":"Association of the endobiont double-stranded RNA virus LRV1 with treatment failure for human leishmaniasis caused by Leishmania braziliensis in Peru and Bolivia","volume":"213","author":"Adaui","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0031182010001095","article-title":"Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony","volume":"138","author":"Adaui","year":"2011","journal-title":"Parasitology"},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib4","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1128\/AAC.45.6.1928-1929.2001","article-title":"In vitro growth of Leishmania amazonensis promastigotes resistant to pentamidine is dependent on interactions among strains","volume":"45","author":"Agnew","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib5","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/AAC.00809-10","article-title":"Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis","volume":"54","author":"Aguiar","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib6","first-page":"181","article-title":"Gene expression of RNAP II, JBP1 and JBP2 in Leishmania major exposed to antimonials, amphotericin B and paromomycin","volume":"64","author":"Ajamein","year":"2018","journal-title":"Ann. Parasitol."},{"key":"10.1016\/bs.apar.2025.09.001_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.actatropica.2017.04.029","article-title":"Application of nanotechnology in treatment of leishmaniasis: a review","volume":"172","author":"Akbari","year":"2017","journal-title":"Acta Tropica"},{"issue":"5924","key":"10.1016\/bs.apar.2025.09.001_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.1169464","article-title":"Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector","volume":"324","author":"Akopyants","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41467-024-55538-7","article-title":"TransLeish: identification of membrane transporters essential for survival of intracellular Leishmania parasites in a systematic gene deletion screen","volume":"16","author":"Albuquerque-Wendt","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib10","doi-asserted-by":"crossref","first-page":"8385672","DOI":"10.1155\/2020\/8385672","article-title":"Whole blood stimulation assay as a treatment outcome monitoring tool for VL patients in Ethiopia: a pilot evaluation","volume":"2020","author":"Aleka","year":"2020","journal-title":"J. Immunology Res."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib11","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/AAC.49.8.3274-3280.2005","article-title":"Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana","volume":"49","author":"Al-Mohammed","year":"2005","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41597-021-01017-3","article-title":"Chromosome-scale genome sequencing, assembly and annotation of six genomes from subfamily Leishmaniinae","volume":"8","author":"Almutairi","year":"2021","journal-title":"Sci. Data"},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib13","article-title":"Amphotericin B resistance in Leishmania Mexicana: alterations to sterol metabolism and oxidative stress response","volume":"16","author":"Alpizar-Sosa","year":"2022","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol.\u00a0Rev."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin. Microbiol.\u00a0Rev."},{"key":"10.1016\/bs.apar.2025.09.001_bib16","series-title":"Advances in Parasitology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(04)57001-X","article-title":"Canine leishmaniasis","author":"Alvar","year":"2004"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/TP.0b013e31827c16e2","article-title":"The risk factors for and effects of visceral leishmaniasis in graft and renal transplant recipients","volume":"95","author":"Alves da Silva","year":"2013","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijantimicag.2017.06.007","article-title":"Amiodarone and itraconazole improve the activity of pentavalent antimonial in the treatment of experimental cutaneous leishmaniasis","volume":"50","author":"Anversa","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/bs.apar.2025.09.001_bib20","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0211-2018","article-title":"Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: a case series","volume":"52","author":"Arboleda","year":"2019","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib21","article-title":"ABCI3 is a new mitochondrial ABC transporter from Leishmania major involved in susceptibility to antimonials and infectivity","volume":"61","author":"Arcari","year":"2017","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib22","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"Arevalo","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2230.2006.02182.x","article-title":"Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: A placebo\u2010controlled, randomized clinical trial","volume":"31","author":"Asilian","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime\u00ae) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime\u00ae) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int. J. Dermatol."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.celrep.2015.09.058","article-title":"Exosome secretion by the parasitic protozoan Leishmania within the sand fly midgut","volume":"13","author":"Atayde","year":"2015","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41564-018-0352-y","article-title":"Exploitation of the Leishmania exosomal pathway by Leishmania RNA virus 1","volume":"4","author":"Atayde","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/pathogens13090812","article-title":"Advances in Leishmania vaccines: current development and future prospects","volume":"13","author":"Ayala","year":"2024","journal-title":"Pathogens"},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib28","first-page":"812","article-title":"Advances in Leishmania vaccines: current development and future prospects","volume":"13","author":"Ayala","year":"2024","journal-title":"Pathog. (Basel, Switz.)"},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009099","article-title":"Therapeutic advances in the topical treatment of cutaneous leishmaniasis: a review","volume":"15","author":"Azim","year":"2021","journal-title":"PLOS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1742-7843.2005.pto960109.x","article-title":"Leishmanicidal activity of edelfosine, miltefosine and ilmofosine","volume":"96","author":"Azzouz","year":"2005","journal-title":"Basic. & Clin. Pharmacol. & Toxicol."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/cmdc.201300176","article-title":"Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography","volume":"8","author":"Baiocco","year":"2013","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib32","article-title":"Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: a prospective case-control study on treatment outcome and their medical importance","volume":"15","author":"Bamorovat","year":"2021","journal-title":"PLOS Negl.\u00a0Trop.\u00a0Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib33","unstructured":"Baneth,\u00a0G., 2017.\u00a0World small animal veterinary association congress proceedings, 2017. VIN.com. Epub ahead of print 25 September 2017."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib34","article-title":"A plant like cytochrome P450 subfamily CYP710C1 gene in Leishmania donovani encodes sterol C-22 desaturase and its over-expression leads to resistance to amphotericin B","volume":"13","author":"Bansal","year":"2019","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib35","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jac\/dkz515","article-title":"Stigmasterol as a potential biomarker for amphotericin B resistance in Leishmania donovani","volume":"75","author":"Bansal","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12669\/pjms.35.6.363","article-title":"Comparison of intralesional meglumine antimonite along withoral itraconazole to intralesional meglumine antimonitein the treatment of cutaneous Leishmaniasis","volume":"35","author":"Bashir","year":"2019","journal-title":"Pak. J. Med. Sci."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-6851(00)00234-6","article-title":"Putrescine and spermidine transport in Leishmania","volume":"109","author":"Basselin","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib38","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/AAC.46.12.3731-3738.2002","article-title":"Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion","volume":"46","author":"Basselin","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s004360050529","article-title":"The efficacy of pentamidine combined with allopurinol and immunotherapy for the treatment of patients with diffuse cutaneous leishmaniasis","volume":"85","author":"Becker","year":"1999","journal-title":"Parasitol. Res."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009654","article-title":"Experimental transmission of Leishmania (Mundinia) parasites by biting midges (Diptera: Ceratopogonidae)","volume":"17","author":"Becvar","year":"2021","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib41","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","author":"Ben Salah","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/pharmaceutics16020227","article-title":"The potential use of peptides in the fight against chagas disease and leishmaniasis","volume":"16","author":"Berhe","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apar.2025.09.001_bib44","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.1981.30.318","article-title":"Effect of temperature on multiplication of leishmania amastigotes within human monocyte-derived macrophages in vitro","author":"Berman","year":"1981","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib45","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1128\/AAC.01574-13","article-title":"Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani","volume":"58","author":"Bhandari","year":"2014","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib46","first-page":"12500","article-title":"Genomic Insight of Leishmania parasite: in-depth review of drug resistance mechanisms and genetic mutations","volume":"9","author":"Bharadava","year":"2024","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib47","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/jac\/dks159","article-title":"Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection","volume":"67","author":"Bhattacharjee","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15698\/mic2020.02.708","article-title":"New insights in the mode of action of anti-leishmanial drugs by using chemical mutagenesis screens coupled to next-generation sequencing","volume":"7","author":"Bhattacharya","year":"2020","journal-title":"Microb. Cell (Graz, Austria)"},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib49","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/genes11070722","article-title":"Of drugs and trypanosomatids: new tools and knowledge to reduce bottlenecks in drug discovery","volume":"11","author":"Bhattacharya","year":"2020","journal-title":"Genes"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib50","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1038\/s41467-019-13344-6","article-title":"Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania","volume":"10","author":"Bhattacharya","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.apar.2025.09.001_bib51","series-title":"Challenges and solutions against visceral leishmaniasis","first-page":"325","article-title":"Toward a safe and efficacious pan-leishmania vaccine","author":"Bhattacharya","year":"2023"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.25259\/IJMR_569_2024","article-title":"Possibility of re-purposing antifungal drugs posaconazole & isavuconazole against promastigote form of Leishmania major","volume":"160","author":"Bhusal","year":"2024","journal-title":"Indian. J. Med. Res."},{"key":"10.1016\/bs.apar.2025.09.001_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9872095","article-title":"Current visceral leishmaniasis research: a research review to inspire future study","volume":"2018","author":"Bi","year":"2018","journal-title":"BioMed. Res. Int."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molbiopara.2011.06.004","article-title":"Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani","volume":"179","author":"Biyani","year":"2011","journal-title":"Mol. Biochem.\u00a0Parasitol."},{"key":"10.1016\/bs.apar.2025.09.001_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1102462","article-title":"Life in plastic, it\u2019s fantastic! How Leishmania exploit genome instability to shape gene expression","volume":"13","author":"Black","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib56","article-title":"Human genetics of leishmania infections","volume":"139","author":"Blackwell","year":"2020","journal-title":"Hum. Genet."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001019","article-title":"Transplacental transmission of leishmania infantum as a means for continued disease incidence in North America","volume":"5","author":"Boggiatto","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib58","article-title":"Leishmaniasis: a new method for confirming cure and detecting asymptomatic infection in patients receiving immunosuppressive treatment for autoimmune disease","volume":"15","author":"Botana","year":"2021","journal-title":"PLOS Negl.\u00a0Trop. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib59","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fcimb.2018.00381","article-title":"Cellular markers of active disease and cure in different forms of leishmania infantum-induced disease","volume":"8","author":"Botana","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiv355","article-title":"Presence of Leishmania RNA virus 1 in Leishmania guyanensis increases the risk of first-line treatment failure and symptomatic relapse","volume":"213","author":"Bourreau","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-025-01070-8","article-title":"LmCen\u2212\/\u2212 based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia","volume":"10","author":"Boussoffara","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/bs.apar.2025.09.001_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111660","article-title":"Multi-target drugs active against leishmaniasis: a paradigm of drug repurposing","volume":"183","author":"Braga","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"726","key":"10.1016\/bs.apar.2025.09.001_bib63","doi-asserted-by":"crossref","first-page":"eadh9902","DOI":"10.1126\/scitranslmed.adh9902","article-title":"DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1","volume":"15","author":"Braillard","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081899","article-title":"Proteomic and genomic analyses of antimony resistant Leishmania infantum mutant","volume":"8","author":"Brotherton","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib65","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpddr.2014.05.002","article-title":"Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum","volume":"4","author":"Brotherton","year":"2014","journal-title":"Int. J. Parasitol.\u00a0Drugs Drug. Resistance"},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00995-24","article-title":"Genomic and epidemiological evidence for the emergence of a L. infantum\/L. donovani hybrid with unusual epidemiology in northern Italy","volume":"15","author":"Bruno","year":"2024","journal-title":"mBio"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib67","article-title":"Post Kala-Azar dermal leishmaniasis following treatment with 20 mg\/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India","volume":"8","author":"Burza","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib68","article-title":"Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg\/kg liposomal amphotericin B (Ambisome) in Bihar, India","volume":"8","author":"Burza","year":"2014","journal-title":"PLOS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib69","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01399-18","article-title":"Leishmania genome dynamics during environmental adaptation reveal strain-specific differences in gene copy number variation, karyotype instability, and telomeric amplification","volume":"9","author":"Bussotti","year":"2018","journal-title":"mBio"},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib70","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10822-019-00230-y","article-title":"Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations","volume":"33","author":"Bustamante","year":"2019","journal-title":"J. Comput. Mol. Des."},{"key":"10.1016\/bs.apar.2025.09.001_bib71","article-title":"Photodynamic therapy offers a novel approach to managing miltefosine-resistant cutaneous leishmaniasis","volume":"177","author":"Cabral","year":"2024","journal-title":"Biomed.\u00a0Pharmacother."},{"issue":"43","key":"10.1016\/bs.apar.2025.09.001_bib72","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1016\/j.vaccine.2020.08.051","article-title":"Immunoprophylaxis pharmacotherapy against canine leishmaniosis: a systematic review and meta-analysis on the efficacy of vaccines approved in European Union","volume":"38","author":"Calzetta","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib73","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1038\/s41598-019-42511-4","article-title":"Complete assembly of the Leishmania donovani (HU3 strain) genome and transcriptome annotation","volume":"9","author":"Camacho","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib74","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/genes12091359","article-title":"Gene annotation and transcriptome delineation on a de novo genome assembly for the reference leishmania major friedlin strain","volume":"12","author":"Camacho","year":"2021","journal-title":"Genes"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib75","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00436-009-1418-9","article-title":"Identification and chromosomal localization of one locus of Leishmania (L.) major related with resistance to itraconazole","volume":"105","author":"Camizotti","year":"2009","journal-title":"Parasitol. Res."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1590\/S0036-46652014000400005","article-title":"Participation of ticks in the infectious cycle of canine visceral leishmaniasis, in Teresina, Piau\u00ed, BraziL","volume":"56","author":"Campos","year":"2014","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"key":"10.1016\/bs.apar.2025.09.001_bib77","unstructured":"Canadian Food Inspection Agency, 2024.\u00a0Bringing animals to Canada: importing and travelling with pets. Available at: http:\/\/inspection.canada.ca\/en\/importing-food-plants-animals\/pets (Accessed 4 April 2025)."},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004079","article-title":"Further evidence of an association between the presence of leishmania RNA virus 1 and the mucosal manifestations in tegumentary leishmaniasis patients","volume":"9","author":"Cantanh\u00eade","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104378","article-title":"3\u2019Nucleotidase\/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine","volume":"86","author":"Carnielli","year":"2022","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004179","article-title":"Cytokine release assays as tests for exposure to leishmania, and for confirming cure from leishmaniasis, in solid organ transplant recipients","volume":"9","author":"Carrillo","year":"2015","journal-title":"PLOS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.50.1.88-95.2006","article-title":"Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase","volume":"50","author":"Carter","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68953-9","article-title":"Application of next generation sequencing (NGS) for descriptive analysis of 30 genomes of Leishmania infantum isolates in Middle-North Brazil","volume":"10","author":"Carvalho","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib83","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/AAC.00520-11","article-title":"The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase","volume":"55","author":"Carvalho","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib84","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.00790-10","article-title":"Tafenoquine, an antiplasmodial 8-aminoquinoline, targets leishmania respiratory complex III and induces apoptosis","volume":"54","author":"Carvalho","year":"2010","journal-title":"Antimicrobi. Agents Chemother."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib85","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s15010-011-0109-5","article-title":"Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment","volume":"39","author":"Casabianca","year":"2011","journal-title":"Infection"},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib86","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1128\/AAC.00587-08","article-title":"Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement","volume":"52","author":"Castanys-Mu\u00f1oz","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.apar.2025.09.001_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2024.105323","article-title":"Characterizing Leishmania infantum-induced resistance to trivalent stibogluconate (SbIII) through deep proteomics","volume":"309","author":"Castillo-Casta\u00f1eda","year":"2024","journal-title":"J. Proteom"},{"key":"10.1016\/bs.apar.2025.09.001_bib88","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.actatropica.2016.09.026","article-title":"Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients","volume":"164","author":"Castro","year":"2016","journal-title":"Acta Tropica"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005515","article-title":"Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: a cohort study","volume":"11","author":"Castro","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib90","unstructured":"CDC,\u00a02024a. About Leishmaniasis. Available at: https:\/\/www.cdc.gov\/leishmaniasis\/about\/index.html (Accessed 4 April 2025)."},{"key":"10.1016\/bs.apar.2025.09.001_bib91","unstructured":"CDC, 2024b.\u00a0Entry requirements for foreign-vaccinated dogs from high-risk countries. Available at: https:\/\/www.cdc.gov\/importation\/dogs\/foreign-vaccinated-high-risk-countries.html (Accessed 4 April 2025)."},{"key":"10.1016\/bs.apar.2025.09.001_bib92","first-page":"1251","article-title":"Current and\u00a0emerging medications for the treatment of leishmaniasis","volume":"20","author":"Chakravarty","year":"2019"},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262158","article-title":"The role of Leishmania GP63 in the modulation of innate inflammatory response to Leishmania major infection","volume":"16","author":"Chan","year":"2021","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib94","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/cei.13014","article-title":"Redundant and regulatory roles for toll-like receptors in Leishmania infection","volume":"190","author":"Chauhan","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026660","article-title":"Paromomycin affects translation and vesicle-mediated trafficking as revealed by proteomics of paromomycin -susceptible -resistant Leishmania donovani","volume":"6","author":"Chawla","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.apar.2025.09.001_bib96","article-title":"Estimating the proportion of relapse following treatment of visceral leishmaniasis: meta-analysis using Infectious diseases data observatory (IDDO) systematic review","volume":"22","author":"Chhajed","year":"2024","journal-title":"Lancet Reg.\u00a0Health. Southeast. Asia"},{"issue":"8\u20139","key":"10.1016\/bs.apar.2025.09.001_bib97","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.annder.2012.05.013","article-title":"Unusual clinical presentation of cutaneous leishmaniasis in three diabetic patients","volume":"139","author":"Chiheb","year":"2012","journal-title":"Annales De. Dermatologie Et. De Venereologie"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib98","article-title":"Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib99","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.exppara.2008.03.018","article-title":"Characterization of Leishmania (Leishmania) amazonensis promastigotes resistant to pentamidine","volume":"120","author":"Coelho","year":"2008","journal-title":"Exp. Parasitol."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib100","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1128\/AAC.00404-07","article-title":"Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes","volume":"51","author":"Coelho","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib101","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpddr.2015.05.006","article-title":"Leishmania is not prone to develop resistance to tamoxifen","volume":"5","author":"Coelho","year":"2015","journal-title":"Int. J. Parasitol.\u00a0Drugs Drug. Resist."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin. & Transl. Immunol."},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib103","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a Recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib104","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib105","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1128\/IAI.71.6.3172-3182.2003","article-title":"Perforin and Gamma interferon are critical CD8+ t-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection","volume":"71","author":"Colmenares","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/bs.apar.2025.09.001_bib106","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fmicb.2018.01308","article-title":"The binomial parasite-host immunity in the healing process and in reactivation of human tegumentary leishmaniasis","volume":"9","author":"Concei\u00e7\u00e3o-Silva","year":"2018","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib107","article-title":"Two women presenting worsening cutaneous ulcers during pregnancy: diagnosis, immune response, and follow-up","volume":"7","author":"Concei\u00e7\u00e3o-Silva","year":"2013","journal-title":"PLoS Neg.\u00a0Trop. Dis."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib108","first-page":"808","article-title":"Initial and long-term efficacy of a lipid emulsion of amphotericin B desoxycholate in the management of canine leishmaniasis","volume":"17","author":"Cortadellas","year":"2003","journal-title":"J. Veterinary Intern. Med."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib109","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.exppara.2007.02.018","article-title":"Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine","volume":"116","author":"Cort\u00e1zar","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/bs.apar.2025.09.001_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.852902","article-title":"Finding correlations between mRNA and protein levels in Leishmania development: is there a discrepancy?","volume":"12","author":"Cortazzo da Silva","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib111","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/pathogens12070969","article-title":"From infection to death: an overview of the pathogenesis of visceral leishmaniasis","volume":"12","author":"Costa","year":"2023","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib112","first-page":"54","article-title":"Immune responses in leishmaniasis: an overview","volume":"7","author":"Costa-da-Silva","year":"2022","journal-title":"Tropical Med. Infect. Dis."},{"issue":"53","key":"10.1016\/bs.apar.2025.09.001_bib113","doi-asserted-by":"crossref","first-page":"37723","DOI":"10.1074\/jbc.274.53.37723","article-title":"Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in Leishmania by overexpression\/selection","volume":"274","author":"Cotrim","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib114","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/expr.1996.0100","article-title":"T-cell responsiveness of american cutaneous leishmaniasis patients to purified\u00a0Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure","volume":"84","author":"Coutinho","year":"1996","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"9312","key":"10.1016\/bs.apar.2025.09.001_bib116","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(02)08160-6","article-title":"Leishmania in discarded syringes from intravenous drug users","volume":"359","author":"Cruz","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib117","first-page":"357","article-title":"Leishmania\/HIV co-infections in the second decade","volume":"123","author":"Cruz","year":"2006","journal-title":"Indian. J. Med. Res."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib118","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4269\/ajtmh.15-0033","article-title":"Efficacy and safety of liposomal amphotericin B for the treatment of mucosal leishmaniasis from the new world: a retrospective study","volume":"93","author":"Cunha","year":"2015","journal-title":"Am. J. Trop.\u00a0Med. Hyg."},{"key":"10.1016\/bs.apar.2025.09.001_bib119","article-title":"Leishmania exosomes\/extracellular vesicles containing GP63 Are essential for enhance cutaneous leishmaniasis development upon co-inoculation of Leishmania amazonensis and its exosomes","volume":"11","author":"da Silva Lira Filho","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pt.2010.12.006","article-title":"Ticks as vectors of Leishmania parasites","volume":"27","author":"Dantas-Torres","year":"2011","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib121","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13071-024-06282-w","article-title":"Canine leishmaniasis in the Americas: etiology, distribution, and clinical and zoonotic importance","volume":"17","author":"Dantas-Torres","year":"2024","journal-title":"Parasites & Vectors"},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2512.190164","article-title":"Canine leishmaniasis control in the context of one health","volume":"25","author":"Dantas-Torres","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105256","article-title":"Nano-elastic liposomes as multidrug carrier of sodium stibogluconate and ketoconazole: a potential new approach for the topical treatment of cutaneous Leishmaniasis","volume":"145","author":"Dar","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib124","article-title":"Functional involvement of Leishmania donovani tryparedoxin peroxidases during infection and drug treatment","volume":"62","author":"Das","year":"2018","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"key":"10.1016\/bs.apar.2025.09.001_bib125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13071-016-1388-6","article-title":"First report of autochthonous non-vectorial canine leishmaniasis in New Caledonia, south-western Pacific: implications for new control measures and recommendations on importation of dogs","volume":"9","author":"Daval","year":"2016","journal-title":"Parasites & Vectors"},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib126","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1128\/AAC.01150-15","article-title":"Potent in vitro antiproliferative synergism of combinations of ergosterol biosynthesis inhibitors against Leishmania amazonensis","volume":"59","author":"de Macedo-Silva","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"21","key":"10.1016\/bs.apar.2025.09.001_bib127","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1016\/j.bmc.2014.08.020","article-title":"Thymol and eugenol derivatives as potential antileishmanial agents","volume":"22","author":"de Morais","year":"2014","journal-title":"Bioorg.\u00a0Med.\u00a0Chem."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jac\/dkt318","article-title":"In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species","volume":"69","author":"de Morais-Teixeira","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib129","article-title":"Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress","volume":"11","author":"Deep","year":"2017","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0304-4165(02)00198-8","article-title":"Antimony(V) complex formation with adenine nucleosides in aqueous solution","volume":"1570","author":"Demicheli","year":"2002","journal-title":"Biochimica Et. Biophys.\u00a0Acta"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1939-1676.1999.tb01455.x","article-title":"Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases)","volume":"13","author":"Denerolle","year":"1999","journal-title":"J. Veterinary Intern. Med."},{"key":"10.1016\/bs.apar.2025.09.001_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2024.108826","article-title":"The nexus between Leishmania & HIV: Debilitating host immunity and Hastening Comorbid disease burden","volume":"265","author":"Dhulipalla","year":"2024","journal-title":"Exp. Parasitol."},{"key":"10.1016\/bs.apar.2025.09.001_bib133","article-title":"Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis","volume":"217","author":"Dias \u00c1F de","year":"2020","journal-title":"Exp. Parasitol."},{"key":"10.1016\/bs.apar.2025.09.001_bib134","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biochi.2025.03.007","article-title":"Molecular and biochemical approaches of the trypanothione system in Leishmania spp.: a key player in parasite resistance to antimonial therapy","volume":"234","author":"Dias-Lopes","year":"2025","journal-title":"Biochimie"},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3347\/kjp.2022.60.6.379","article-title":"Leishmania vaccines: the current situation with its promising aspect for the future","volume":"60","author":"Dinc","year":"2022","journal-title":"Korean J. Parasitol."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib136","article-title":"High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia","volume":"8","author":"Diro","year":"2014","journal-title":"PLOS Negl. Trop.\u00a0Dis."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib137","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1473-3099(14)70833-3","article-title":"Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings","volume":"15","author":"Diro","year":"2015","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib138","article-title":"Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress","volume":"117","author":"do Monte","year":"2022","journal-title":"Mem\u00f3rias do Inst. Oswaldo Cruz"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib139","article-title":"Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis","volume":"5","author":"do Monte-Neto","year":"2011","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2021.04.003","article-title":"Extracellular vesicles and leishmaniasis: current knowledge and promising avenues for future development","volume":"135","author":"Dong","year":"2021","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111121","article-title":"Leishmania parasites exchange drug-resistance genes through extracellular vesicles","volume":"40","author":"Douanne","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/bs.apar.2025.09.001_bib142","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpddr.2020.03.003","article-title":"MRPA-independent mechanisms of antimony resistance in Leishmania infantum","volume":"13","author":"Douanne","year":"2020","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib143","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.meegid.2011.11.005","article-title":"Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex","volume":"12","author":"Downing","year":"2012","journal-title":"Infection, Genet. Evolution: J. Mol. Epidemiol. Evolut. Genet. Infect. Dis."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib144","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jac\/dky450","article-title":"Miltefosine enhances the fitness of a non-virulent drug-resistant Leishmania infantum strain","volume":"74","author":"Eberhardt","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exppara.2009.05.013","article-title":"Down regulation of KMP-11 in Leishmania infantum axenic antimony resistant amastigotes as revealed by a proteomic screen","volume":"123","author":"El Fadili","year":"2009","journal-title":"Exp. Parasitol."},{"key":"10.1016\/bs.apar.2025.09.001_bib146","article-title":"Host immune response against leishmaniasis and parasite persistence strategies: a review and assessment of recent research","volume":"139","author":"Elmahallawy","year":"2021","journal-title":"Biomed.\u00a0Pharmacother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib147","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s42269-019-0227-2","article-title":"Toll-like receptors activation, signaling, and targeting: an overview","volume":"43","author":"El-Zayat","year":"2019","journal-title":"Bull. Natl Res. Cent"},{"key":"10.1016\/bs.apar.2025.09.001_bib148","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85605","article-title":"Gene editing and scalable functional genomic screening in Leishmania species using the CRISPR\/Cas9 cytosine base editor toolbox LeishBASEedit","volume":"12","author":"Engstler","year":"2023","journal-title":"eLife"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib149","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/bjd.13490","article-title":"Cutaneous leishmaniasis responds to daylight\u2010activated photodynamic therapy: proof of concept for a novel self\u2010administered therapeutic modality","volume":"172","author":"Enk","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib150","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/acsinfecdis.0c00857","article-title":"Ros3 (Lem3p\/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major","volume":"7","author":"Espada","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib151","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpddr.2019.02.005","article-title":"Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake","volume":"11","author":"Espada","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib152","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.diagmicrobio.2018.03.004","article-title":"Identification of Leishmania (Viannia) species and clinical isolates of Leishmania (Leishmania) amazonensis from Brazil using PCR-RFLP of the heat-shock protein 70 gene reveals some unexpected observations","volume":"91","author":"Espada","year":"2018","journal-title":"Diagn.\u00a0Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib153","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s12639-014-0641-1","article-title":"Topical terbinafine in the treatment of cutaneous leishmaniasis: triple blind randomized clinical trial","volume":"40","author":"Farajzadeh","year":"2016","journal-title":"J. Parasitic Diseases: Off. Organ. Indian. Soc. Parasitol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib154","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4049\/jimmunol.1002175","article-title":"Leishmania inhibitor of serine peptidase 2 prevents TLR4 activation by neutrophil elastase promoting parasite survival in murine macrophages","volume":"186","author":"Faria","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/AAC.00506-10","article-title":"Differential effects of paromomycin on ribosomes of Leishmania mexicana and mammalian cells","volume":"55","author":"Fern\u00e1ndez","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.117","article-title":"Guidelines for the purification and characterization of extracellular vesicles of parasites","volume":"2","author":"Fernandez-Becerra","year":"2023","journal-title":"J. Extracell. Biol"},{"key":"10.1016\/bs.apar.2025.09.001_bib157","series-title":"In Silico Drug Design","first-page":"119","article-title":"Chapter 5 - Repurposed molecules: A new hope in tackling neglected infectious diseases","author":"Fern\u00e1ndez-Prada","year":"2019"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib158","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpddr.2018.03.004","article-title":"High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms","volume":"8","author":"Fernandez-Prada","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005171","article-title":"Different mutations in a P-type ATPase transporter in Leishmania parasites are associated with cross-resistance to two leading drugs by distinct mechanisms","volume":"10","author":"Fernandez-Prada","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/A:1022823605068","article-title":"Thiol-induced reduction of antimony(V) into antimony(III): a comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione","volume":"16","author":"Ferreira","year":"2003","journal-title":"Biometals: An. Int. J. Role Met. Ions Biology, Biochemistry, Med."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib161","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-2958.2007.05845.x","article-title":"Biochemical characterization of Leishmania major aquaglyceroporin LmAQP1: possible role in volume regulation and osmotaxis","volume":"65","author":"Figarella","year":"2007","journal-title":"Mol. Microbiol."},{"issue":"14","key":"10.1016\/bs.apar.2025.09.001_bib162","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/bs.apar.2025.09.001_bib163","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51243","article-title":"Global genome diversity of the Leishmania donovani complex","volume":"9","author":"Franssen","year":"2020","journal-title":"eLife"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib164","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1039\/c2mt00176d","article-title":"Greater binding affinity of trivalent antimony to a CCCH zinc finger domain compared to a CCHC domain of kinetoplastid proteins","volume":"4","author":"Fr\u00e9zard","year":"2012","journal-title":"Metallomics: Integr. Biometal Sci."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib165","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1067\/mjd.2003.218","article-title":"Treatment of cutaneous leishmaniasis by photodynamic therapy","volume":"48","author":"Gardlo","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"issue":"21","key":"10.1016\/bs.apar.2025.09.001_bib166","doi-asserted-by":"crossref","first-page":"E3012","DOI":"10.1073\/pnas.1520693113","article-title":"Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania","volume":"113","author":"Gazanion","year":"2016","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib167","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molbiopara.2007.11.008","article-title":"A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes","volume":"158","author":"Genest","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib168","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/nar\/gkv118","article-title":"Roles of Rad51 paralogs for promoting homologous recombination in Leishmania infantum","volume":"43","author":"Genois","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib169","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s00436-022-07645-x","article-title":"Genome-wide analysis reveals allelic variation and chromosome copy number variation in paromomycin-resistant Leishmania donovani","volume":"121","author":"Ghosh","year":"2022","journal-title":"Parasitol. Res."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib170","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04026-23","article-title":"Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era","volume":"12","author":"Ghosh","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"26","key":"10.1016\/bs.apar.2025.09.001_bib171","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib172","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s13071-021-05100-x","article-title":"Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol","volume":"14","author":"Gon\u00e7alves","year":"2021","journal-title":"Parasites & Vectors"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib173","article-title":"Therapeutic success and failure in using miltefosine to treat dogs naturally infected with Leishmania infantum","volume":"33","author":"Gon\u00e7alves","year":"2024","journal-title":"Rev. Brasileira De. Parasitologia Veterinaria = Braz. J. Veterinary Parasitology: Orgao Oficial Do Col. Brasileiro De Parasitologia Veterinaria"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib174","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4269\/ajtmh.19-0931","article-title":"Combination therapy against indian visceral leishmaniasis with liposomal Amphotericin B (FungisomeTM) and short-course miltefosine in comparison to miltefosine monotherapy","volume":"103","author":"Goswami Rama Prosad","year":"2020","journal-title":"Am. J. Trop.\u00a0Med. Hyg."},{"issue":"30","key":"10.1016\/bs.apar.2025.09.001_bib175","doi-asserted-by":"crossref","first-page":"31010","DOI":"10.1074\/jbc.M403959200","article-title":"Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin","volume":"279","author":"Gourbal","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.apar.2025.09.001_bib176","first-page":"286","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"Griensven","year":"2014"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib177","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/AAC.01014-09","article-title":"Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions","volume":"54","author":"Griewank","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1\u20132","key":"10.1016\/bs.apar.2025.09.001_bib178","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-2427(02)00128-9","article-title":"Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis","volume":"88","author":"Guarga","year":"2002","journal-title":"Vet. Immunol.\u00a0Immunopathol."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib179","article-title":"Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-\u03b2 in early immune response","volume":"8","author":"Guha","year":"2014","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib180","first-page":"1018","article-title":"The Leishmania skin test predicts clinic-immunologic and therapeutic outcomes in cutaneous leishmaniasis","volume":"13","author":"Guimar\u00e3es","year":"2024","journal-title":"Pathog. (Basel, Switz.)"},{"issue":"20","key":"10.1016\/bs.apar.2025.09.001_bib181","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1093\/nar\/gkg806","article-title":"Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays","volume":"31","author":"Guimond","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib182","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/jac\/dku422","article-title":"Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis","volume":"70","author":"Gupta","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib183","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/s41467-023-38221-1","article-title":"Translational reprogramming as a driver of antimony-drug resistance in Leishmania","volume":"14","author":"Gutierrez Guarnizo","year":"2023","journal-title":"Nat. Commun"},{"key":"10.1016\/bs.apar.2025.09.001_bib184","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol. Biol. Int."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000907","article-title":"Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation","volume":"6","author":"Haldar","year":"2010","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095007","article-title":"Absence of metalloprotease GP63 alters the protein content of Leishmania exosomes","volume":"9","author":"Hassani","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib187","article-title":"Therapeutic effect of topical tamoxifen in murine cutaneous leishmaniasis caused by Leishmania major","volume":"68","author":"Hassani-Abharian","year":"2024","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"issue":"02","key":"10.1016\/bs.apar.2025.09.001_bib188","doi-asserted-by":"crossref","first-page":"84","DOI":"10.55184\/ijpas.v75i02.163","article-title":"A brief report on eugenol oleate is an oral immunomodulatory molecule against visceral leishmaniasis","volume":"75","author":"Hazra","year":"2023","journal-title":"Indian. J. of. Physiol. and. Allied Sci."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib189","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","article-title":"Exploiting knowledge on leishmania drug resistance to support the quest for new drugs","volume":"33","author":"Hefnawy","year":"2017","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib190","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30040-5","article-title":"Importance of secondary screening with clinical isolates for anti-leishmania drug discovery","volume":"8","author":"Hefnawy","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib191","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00436-014-3835-7","article-title":"Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum","volume":"113","author":"Hendrickx","year":"2014","journal-title":"Parasitol. Res."},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib192","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140139","article-title":"Comparative fitness of a parent leishmania donovani clinical isolate and its experimentally derived paromomycin-resistant strain","volume":"10","author":"Hendrickx","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib193","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/jac\/dkz517","article-title":"Transmission potential of paromomycin-resistant Leishmania infantum and Leishmania donovani","volume":"75","author":"Hendrickx","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib194","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/microorganisms9081546","article-title":"Experimental selection of paromomycin resistance in Leishmania donovani amastigotes induces variable genomic polymorphisms","volume":"9","author":"Hendrickx","year":"2021","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib195","article-title":"Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum","volume":"11","author":"Hendrickx","year":"2017","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib196","first-page":"4061","article-title":"Leishmanial protein kinases phosphorylate components of the complement system","author":"Hermoso","year":"1991"},{"key":"10.1016\/bs.apar.2025.09.001_bib197","unstructured":"HIV.gov, 2024.\u00a0Leishmaniasis: adult and adolescent OIs | NIH. Available at: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/leishmaniasis (Accessed 9 April 2025)."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib198","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pt.2025.01.001","article-title":"Vaccines in a time of global boiling and megacities","volume":"41","author":"Hotez","year":"2025","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib199","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pt.2019.10.005","article-title":"New strategies and biomarkers for the control of visceral leishmaniasis","volume":"36","author":"Ibarra-Meneses","year":"2020","journal-title":"Trends Parasitol."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib200","article-title":"The malnutrition-related increase in early visceralization of Leishmania donovani is associated with a reduced number of lymph node phagocytes and altered conduit system flow","volume":"7","author":"Ibrahim","year":"2013","journal-title":"PLoS Negl.\u00a0Trop.\u00a0Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib201","first-page":"1897","article-title":"Immunotherapies and immunomodulatory approaches in clinical trials - a mini review","volume":"17","author":"Iqbal Yatoo Mohd","year":"2021"},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib202","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22194","article-title":"Susceptibility of Leishmania to novel pentavalent organometallics: investigating impact on DNA and membrane integrity in antimony(III)-sensitive and -resistant strains","volume":"85","author":"Islam","year":"2024","journal-title":"Drug. Dev. Res."},{"key":"10.1016\/bs.apar.2025.09.001_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01788","article-title":"Immunization with live attenuated Leishmania donovani centrin\u2212\/\u2212 parasites is efficacious in asymptomatic infection","author":"Ismail","year":"2017","journal-title":"Front.\u00a0Immunol."},{"issue":"6018","key":"10.1016\/bs.apar.2025.09.001_bib204","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1126\/science.1199326","article-title":"Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis","volume":"331","author":"Ives","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib205","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2958.2008.06154.x","article-title":"Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence","volume":"68","author":"Iyer","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/bs.apar.2025.09.001_bib206","first-page":"653","article-title":"Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map. 45","author":"Jain","year":"2024","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/bs.apar.2025.09.001_bib207","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.actatropica.2017.03.006","article-title":"Domestic dogs as reservoir hosts for Leishmania donovani in the southernmost Western Ghats in India","volume":"171","author":"Jambulingam","year":"2017","journal-title":"Acta Tropica"},{"key":"10.1016\/bs.apar.2025.09.001_bib208","article-title":"Genome analyses of amphotericin B-susceptible and -resistant strains of Leishmania (Mundinia) martiniquensis reveal variations potentially related to amphotericin B resistance","volume":"7","author":"Jariyapan","year":"2025","journal-title":"Curr. Res. Parasitol.\u00a0Vector-Borne Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib209","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/695382","article-title":"Antimony resistance in leishmania, focusing on experimental research","volume":"2011","author":"Jeddi","year":"2011","journal-title":"J. Trop. Med."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib210","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.01204-20","article-title":"Chromatin-associated protein complexes link DNA base J and transcription termination in Leishmania","volume":"6","author":"Jensen","year":"2021","journal-title":"mSphere"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib211","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012143","article-title":"Microbial extracellular vesicles contribute to antimicrobial resistance","volume":"20","author":"Jiang","year":"2024","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib212","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s41182-023-00549-1","article-title":"Follow-up assessment of visceral leishmaniasis treated patients and the impact of COVID-19 on control services in Nepal","volume":"51","author":"Joshi","year":"2023","journal-title":"Tropical Med. Health"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib213","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1017\/S0031182013001959","article-title":"Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB\/c mice","volume":"141","author":"Joshi","year":"2014","journal-title":"Parasitology"},{"issue":"10\u201311","key":"10.1016\/bs.apar.2025.09.001_bib214","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00249-014-0983-8","article-title":"Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments","volume":"43","author":"Kami\u0144ski","year":"2014","journal-title":"Eur. biophysics journal: EBJ"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13028-014-0084-9","article-title":"The first report of autochthonous non-vector-borne transmission of canine leishmaniosis in the Nordic countries","volume":"56","author":"Karkamo","year":"2014","journal-title":"Acta Vet. Scand."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib216","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s42003-021-02446-x","article-title":"Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis","volume":"4","author":"Karmakar","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/bs.apar.2025.09.001_bib217","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.vaccine.2023.01.057","article-title":"Vaccine value profile for leishmaniasis","volume":"41","author":"Kaye","year":"2023","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib218","first-page":"442","article-title":"Miltefosine induces metacaspase and PARP genes expression in Leishmania infantum","volume":"15","author":"Khademvatan","year":"2011","journal-title":"Braz. J. Infect. Dis.: An. Off. Publ. Braz. Soc. Infect. Dis."},{"issue":"19","key":"10.1016\/bs.apar.2025.09.001_bib219","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1080\/07391102.2023.2256879","article-title":"Investigating the role of Sterol C24-Methyl transferase mutation on drug resistance in leishmaniasis and identifying potential inhibitors","volume":"42","author":"Khan","year":"2024","journal-title":"J. Biomol.\u00a0Struct. & Dyn."},{"key":"10.1016\/bs.apar.2025.09.001_bib220","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1021464","article-title":"Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients","volume":"12","author":"Khanra","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib221","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09720-1","article-title":"Miltefosine resistant field isolate from Indian Kala-Azar patient shows similar phenotype in experimental infection","volume":"7","author":"Khanra","year":"2017","journal-title":"Sci. Rep."},{"issue":"7619","key":"10.1016\/bs.apar.2025.09.001_bib222","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib223","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/metabo14120658","article-title":"Global lipidomics reveals the lipid composition heterogeneity of extracellular vesicles from drug-resistant Leishmania","volume":"14","author":"Kim","year":"2024","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib224","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s41467-020-15274-0","article-title":"Distinct roles for H4 and H2A.Z acetylation in RNA transcription in African trypanosomes","volume":"11","author":"Kraus","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib225","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1128\/AAC.00812-10","article-title":"Antimony-resistant clinical isolates of Leishmania donovani are susceptible to paromomycin and sitamaquine","volume":"55","author":"Kulshrestha","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.apar.2025.09.001_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138648","article-title":"Characterization of differentially regulated carboxypeptidase (metallopeptidase M32) protein in miltefosine resistant Leishmania donovani parasites","volume":"289","author":"Kumar","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib227","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2010.03716.x","article-title":"Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani","volume":"70","author":"Kumar","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/bs.apar.2025.09.001_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2023.108688","article-title":"In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive\/ sensitive Leishmania donovani promastigotes and intracellular amastigotes","volume":"257","author":"Kumar","year":"2024","journal-title":"Exp. Parasitol."},{"key":"10.1016\/bs.apar.2025.09.001_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174436","article-title":"Advancement in leishmaniasis diagnosis and therapeutics: an update","volume":"910","author":"Kumari","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib230","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.exppara.2011.05.006","article-title":"Leishmania aethiopica: development of specific and sensitive PCR diagnostic test","volume":"128","author":"Kuru","year":"2011","journal-title":"Exp. Parasitol."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib231","article-title":"Dogs as reservoirs for Leishmania donovani, Bihar, India, 2018\u20132022","volume":"30","author":"Kushwaha","year":"2024","journal-title":"Emerg. Infect. Dis.\u00a0J. - CDC"},{"key":"10.1016\/bs.apar.2025.09.001_bib232","doi-asserted-by":"crossref","unstructured":"Lacey,\u00a0C.,\u00a0Musa,\u00a0A.,\u00a0Khalil,\u00a0E.T., et al., 2022. LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasis [version 1; peer review: 2 approved] 7 (200).","DOI":"10.12688\/wellcomeopenres.17951.1"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib233","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.micinf.2013.09.005","article-title":"Constitutive mosaic aneuploidy is a unique genetic feature widespread in the Leishmania genus","volume":"16","author":"Lachaud","year":"2014","journal-title":"Microbes Infect"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib234","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1086\/595710","article-title":"Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum","volume":"48","author":"Lachaud","year":"2009","journal-title":"Clin. Infect. Dis.: An. Off. Publ. Infect. Dis.\u00a0Soc. Am."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004805","article-title":"Formation of linear amplicons with inverted duplications in Leishmania requires the MRE11 nuclease","volume":"10","author":"Laffitte","year":"2014","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib236","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006117","article-title":"Chromosomal translocations in the parasite Leishmania by a MRE11\/RAD50-independent microhomology-mediated end joining mechanism","volume":"12","author":"Laffitte","year":"2016","journal-title":"PLoS Genet."},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib237","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1007\/s00436-016-5195-y","article-title":"Deep-sequencing revealing mutation dynamics in the miltefosine transporter gene in Leishmania infantum selected for miltefosine resistance","volume":"115","author":"Laffitte","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/bs.apar.2025.09.001_bib238","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.12688\/f1000research.9218.1","article-title":"Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance","volume":"5","author":"Laffitte","year":"2016","journal-title":"F1000Research"},{"issue":"28","key":"10.1016\/bs.apar.2025.09.001_bib239","doi-asserted-by":"crossref","first-page":"26301","DOI":"10.1074\/jbc.M102351200","article-title":"The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase","volume":"276","author":"L\u00e9gar\u00e9","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib240","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.pt.2024.06.003","article-title":"LeishGEM: genome-wide deletion mutant fitness and protein localisations in Leishmania","volume":"40","author":"LeishGEM Team","year":"2024","journal-title":"Trends Parasitol."},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib241","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1128\/EC.00152-06","article-title":"Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites","volume":"5","author":"Leprohon","year":"2006","journal-title":"Eukaryot. Cell"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib242","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/nar\/gkn1069","article-title":"Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum","volume":"37","author":"Leprohon","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib243","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1128\/AAC.01474-08","article-title":"Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials","volume":"53","author":"Leprohon","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"46","key":"10.1016\/bs.apar.2025.09.001_bib244","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1016\/j.vaccine.2010.08.092","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis","volume":"28","author":"Llanos-Cuentas","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.clim.2004.07.018","article-title":"Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania","volume":"114","author":"Lodge","year":"2005","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib246","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1051\/parasite\/2011182115","article-title":"Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance","volume":"18","author":"Loiseau","year":"2011","journal-title":"Parasite (Paris, Fr.)"},{"key":"10.1016\/bs.apar.2025.09.001_bib247","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pdpdt.2019.08.020","article-title":"Topical photodynamic therapy with chloroaluminum phthalocyanine liposomes is as effective as systemic pentavalent antimony in the treatment of experimental cutaneous leishmaniasis","volume":"28","author":"Lopes","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/bs.apar.2025.09.001_bib248","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Jaramillo,\u00a0P.,\u00a0Rinc\u00f3n,\u00a0M.Y.,\u00a0Garc\u00eda,\u00a0R.G., et al., 2010. A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis.\u00a0Epub ahead of print 6 July 2010. https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0287.","DOI":"10.4269\/ajtmh.2010.09-0287"},{"issue":"9110","key":"10.1016\/bs.apar.2025.09.001_bib249","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(05)79119-4","article-title":"Treatment of cutaneous leishmaniasis with nitric-oxide donor","volume":"351","author":"Lopez-Jaramillo","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/bs.apar.2025.09.001_bib250","series-title":"eLife","first-page":"e7s3488","article-title":"Stress conditions promote Leishmania hybridization in vitro marked by expression of the ancestral gamete fusogen HAP2 as revealed by single-cell RNA-seq","volume":"vol. 11","author":"Louradour","year":"2022"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.071","article-title":"In vitro generation of Leishmania hybrids","volume":"31","author":"Louradour","year":"2020","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib252","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-3156.2003.01088.x","article-title":"Visceral leishmaniasis and HIV in Tigray, Ethiopia","volume":"8","author":"Lyons","year":"2003","journal-title":"Trop.\u00a0Med. & Int. Health: TM. & IH"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib253","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009079","article-title":"Evidence that a naturally occurring single nucleotide polymorphism in the RagC gene of Leishmania donovani contributes to reduced virulence","volume":"15","author":"Lypaczewski","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib254","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trstmh.2003.08.001","article-title":"Risk factors for mucosal manifestation of American cutaneous leishmaniasis","volume":"99","author":"Machado-Coelho","year":"2005","journal-title":"Trans. R. Soc. Tropical Med. Hyg."},{"issue":"15, 1997","key":"10.1016\/bs.apar.2025.09.001_bib255","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"MacMicking","year":"1997","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib256","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/civ530","article-title":"Combination treatment for visceral leishmaniasis patients coinfected with human immunodeficiency virus in India","volume":"61","author":"Mahajan","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib257","series-title":"Viral, Parasitic, Bacterial, and Fungal Infections","first-page":"429","article-title":"Immunomodulators: progress and prospects in Leishmania infection","author":"Mandal","year":"2023"},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib258","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/jac\/dkp468","article-title":"Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India","volume":"65","author":"Mandal","year":"2010","journal-title":"J. Antimicrob.\u00a0Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib259","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-015-0896-0","article-title":"Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol","volume":"8","author":"Manna","year":"2015","journal-title":"Parasites & Vectors"},{"key":"10.1016\/bs.apar.2025.09.001_bib260","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1156061","article-title":"Amphotericin B resistance correlates with increased fitness in vitro and in vivo in Leishmania (Mundinia) martiniquensis","volume":"14","author":"Mano","year":"2023","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib261","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tvjl.2008.08.009","article-title":"Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis","volume":"182","author":"Manna","year":"2009","journal-title":"Vet.\u00a0J. (London, England: 1997)"},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib262","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/jac\/dkr345","article-title":"Uptake of the antileishmania drug tafenoquine follows a sterol-dependent diffusion process in Leishmania","volume":"66","author":"Manzano","year":"2011","journal-title":"J. Antimicrob.\u00a0Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib263","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13071-017-2198-1","article-title":"Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy","volume":"10","author":"Manzano","year":"2017","journal-title":"Parasites & Vectors"},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib264","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.pt.2022.08.004","article-title":"Extracellular vesicles as a horizontal gene transfer mechanism in Leishmania","volume":"38","author":"Marcilla","year":"2022","journal-title":"Trends Parasitol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib265","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1590\/S0074-02762011000400021","article-title":"Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes","volume":"106","author":"Marinho","year":"2011","journal-title":"Mem. Do Inst. Oswaldo Cruz"},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib266","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1365-2958.2005.04782.x","article-title":"Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania","volume":"57","author":"Marquis","year":"2005","journal-title":"Mol. Microbiol."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib267","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molbiopara.2013.06.006","article-title":"Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines","volume":"190","author":"Matrangolo","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib268","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.42.2.352","article-title":"Mechanism of amphotericin B resistance in Leishmania donovani promastigotes","volume":"42","author":"Mbongo","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib269","first-page":"930","article-title":"Localization of epigenetic markers in Leishmania chromatin","volume":"11","author":"McDonald","year":"2022","journal-title":"Pathog. (Basel, Switz.)"},{"key":"10.1016\/bs.apar.2025.09.001_bib270","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fmicb.2012.00286","article-title":"It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug","volume":"3","author":"Mesa-Arango","year":"2012","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib271","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065467","article-title":"Drug resistance in natural isolates of Leishmania donovani s.l. promastigotes is dependent of Pgp170 expression","volume":"8","author":"Messaritakis","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib272","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 macrophages: Oracles of health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/bs.apar.2025.09.001_bib273","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2020.108033","article-title":"Antileishmanial efficacy and tolerability of combined treatment with non-ionic surfactant vesicle formulations of sodium stibogluconate and paromomycin in dogs","volume":"220","author":"Miret","year":"2021","journal-title":"Exp. Parasitol."},{"issue":"5\u20136","key":"10.1016\/bs.apar.2025.09.001_bib274","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-3164.2009.00824.x","article-title":"Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis","volume":"20","author":"Mir\u00f3","year":"2009","journal-title":"Vet.\u00a0Dermatol."},{"key":"10.1016\/bs.apar.2025.09.001_bib275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155297","article-title":"A historical review of the role of cytokines involved in leishmaniasis","volume":"145","author":"Mirzaei","year":"2021","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib276","first-page":"835","article-title":"Molecular mechanisms of drug resistance in Leishmania spp","volume":"13","author":"Moncada-Diaz","year":"2024","journal-title":"Pathog. (Basel, Switz.)"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib277","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154101","article-title":"Genomic and molecular characterization of miltefosine resistance in Leishmania infantum strains with either natural or acquired resistance through experimental selection of intracellular amastigotes","volume":"11","author":"Mondelaers","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.apar.2025.09.001_bib278","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40265-013-0133-0","article-title":"Therapeutic options for visceral leishmaniasis","volume":"73","author":"Monge-Maillo","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/bs.apar.2025.09.001_bib279","article-title":"Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress","volume":"117","author":"Monte Neto","year":"2022","journal-title":"Mem. Do Inst. Oswaldo Cruz"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib280","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pt.2022.02.001","article-title":"Sex under pressure: stress facilitates Leishmania in vitro hybridization","volume":"38","author":"Monte-Neto","year":"2022","journal-title":"Trends Parasitol."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib281","article-title":"Intrachromosomal amplification, locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis","volume":"9","author":"Monte-Neto","year":"2015","journal-title":"PLoS Neg. Trop.\u00a0Dis."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib282","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3390\/microorganisms11041043","article-title":"Next-generation leishmanization: revisiting molecular targets for selecting genetically engineered live-attenuated Leishmania","volume":"11","author":"Moreira","year":"2023","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib283","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02360-16","article-title":"Meglumine antimoniate (glucantime) causes oxidative stress-derived DNA damage in BALB\/c mice infected by Leishmania (Leishmania) infantum","volume":"61","author":"Moreira","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3\u20134","key":"10.1016\/bs.apar.2025.09.001_bib284","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(99)00096-3","article-title":"The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy","volume":"71","author":"Moreno","year":"1999","journal-title":"Vet.\u00a0Immunol. Immunopathol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib285","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2007.12.032","article-title":"Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis","volume":"58","author":"Mosleh","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib286","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-065X.2010.00983.x","article-title":"Cell biology and immunology of Leishmania","volume":"240","author":"Mougneau","year":"2011","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib287","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/mmi.12178","article-title":"Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania","volume":"88","author":"Mukherjee","year":"2013","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib288","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2005.08.016","article-title":"Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani","volume":"145","author":"Mukherjee","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib289","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.1402585","article-title":"Antimony-resistant Leishmania donovani exploits miR-466i to deactivate host MyD88 for regulating IL-10\/IL-12 levels during early hours of infection","volume":"195","author":"Mukherjee","year":"2015","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib290","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jmb.2008.07.056","article-title":"Structural characterization of the As\/Sb reductase LmACR2 from Leishmania major","volume":"386","author":"Mukhopadhyay","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib291","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/dkt442","article-title":"Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs","volume":"69","author":"Munday","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib292","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1179\/136485905X514127","article-title":"Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL)","volume":"99","author":"Musa","year":"2005","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib293","article-title":"Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study","volume":"4","author":"Musa","year":"2010","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib294","article-title":"Sterol 14\u03b1-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana","volume":"11","author":"Mwenechanya","year":"2017","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"issue":"19","key":"10.1016\/bs.apar.2025.09.001_bib295","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1021\/acs.jmedchem.0c00499","article-title":"Discovery and characterization of clinical candidate LXE408 as a kinetoplastid-selective proteasome inhibitor for the treatment of leishmaniases","volume":"63","author":"Nagle","year":"2020","journal-title":"J. Medicinal Chem"},{"issue":"40","key":"10.1016\/bs.apar.2025.09.001_bib296","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2010.07.063","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis","volume":"28","author":"Nascimento","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/bs.apar.2025.09.001_bib297","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106392","article-title":"Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran","volume":"230","author":"Nateghi-Rostami","year":"2022","journal-title":"Acta Tropica"},{"key":"10.1016\/bs.apar.2025.09.001_bib298","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13071-016-1551-0","article-title":"First report of transmission of canine leishmaniosis through bite wounds from a naturally infected dog in Germany","volume":"9","author":"Naucke","year":"2016","journal-title":"Parasites & Vectors"},{"key":"10.1016\/bs.apar.2025.09.001_bib299","article-title":"Leishmania spp. genetic factors associated with cutaneous leishmaniasis antimony pentavalent drug resistance: a systematic review","volume":"119","author":"Nery","year":"2024","journal-title":"Mem. Do Inst. Oswaldo Cruz"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib300","doi-asserted-by":"crossref","first-page":"e00380","DOI":"10.1128\/msphere.00380-20","article-title":"Lathosterol oxidase (sterol C-5 desaturase) deletion confers resistance to amphotericin B and sensitivity to acidic stress in Leishmania major","volume":"5","author":"Ning","year":"2020","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib301","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpddr.2013.11.004","article-title":"A novel marker, ARM58, confers antimony resistance to Leishmania spp","volume":"4","author":"N\u00fchs","year":"2014","journal-title":"Int. J. Parasitol.\u00a0Drugs Drug. Resist."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib302","first-page":"157","article-title":"Drug repositioning: concept, classification, methodology, and importance in rare\/orphans and neglected diseases","volume":"8","author":"Oliveira","year":"2018","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/bs.apar.2025.09.001_bib303","article-title":"Re-sensitization of antimony-resistant Leishmania by highly potent SbV-porphyrin through the involvement of ERG6-coding gene","volume":"187","author":"Oliveira","year":"2025","journal-title":"Biomed.\u00a0Pharmacother. = Biomed. & Pharmacother."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib304","doi-asserted-by":"crossref","DOI":"10.17648\/uezo-ast-v1i2.13","article-title":"Ecological and social determinants of leishmaniasis in the Legal Amazon, Brazil","volume":"1","author":"Oliveira","year":"2013","journal-title":"Acta Scientiae et. Technicae"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib305","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Tropica"},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib306","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.pt.2019.06.008","article-title":"Leishmania Viannia guyanensis","volume":"35","author":"Olivier","year":"2019","journal-title":"Trends Parasitol."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib307","first-page":"275","article-title":"Alternative non-drug treatment options of the most neglected parasitic disease cutaneous leishmaniasis: a narrative review","volume":"8","author":"Orabi","year":"2023","journal-title":"Tropical Med. Infect. Dis."},{"issue":"24","key":"10.1016\/bs.apar.2025.09.001_bib308","doi-asserted-by":"crossref","first-page":"16164","DOI":"10.1074\/jbc.M109.006718","article-title":"An acid-activated nucleobase transporter from Leishmania major","volume":"284","author":"Ortiz","year":"2009","journal-title":"J. Biol. Chem"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib309","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005527","article-title":"A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: first-in-human trial of ChAd63-KH","volume":"11","author":"Osman","year":"2017","journal-title":"PLOS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib310","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1368-7646(98)80213-6","article-title":"ABC transporters in Leishmania and their role in drug resistance","volume":"1","author":"Ouellette","year":"1998","journal-title":"Drug. Resist.\u00a0Updates"},{"key":"10.1016\/bs.apar.2025.09.001_bib311","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.639801","article-title":"Revival of leishmanization and Leishmanin","volume":"11","author":"Pacheco-Fernandez","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/bs.apar.2025.09.001_bib312","unstructured":"PAHO,\u00a02022.\u00a0Diretrizes para o tratamento das leishmanioses na Regi\u00e3o das Am\u00e9ricas. Available at: https:\/\/iris.paho.org\/handle\/10665.2\/56487."},{"key":"10.1016\/bs.apar.2025.09.001_bib313","unstructured":"PAHO\/WHO Pan American Health Organization, 2020.\u00a0Leishmaniasis. Available at: https:\/\/www.paho.org\/en\/topics\/leishmaniasis (Accessed 26 April 2025)."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib314","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/JCM.05966-11","article-title":"Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India","volume":"50","author":"Pandey","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib315","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12879-024-09211-5","article-title":"Comparing the efficacy of fluconazole and cryotherapy Versus cryotherapy alone on treating cutaneous leishmaniasis: a triple-blind randomized clinical trial","volume":"24","author":"Parhizkar","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib316","article-title":"Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: a triple-blind randomized controlled clinical trial","volume":"11","author":"Parvizi","year":"2017"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib317","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1040638717708391","article-title":"Imported leishmaniasis in a dog in a sandfly-populated area in northeastern Romania","volume":"29","author":"Pavel","year":"2017","journal-title":"J. Vet.\u00a0Diagn. Invest.: Off. Publ. Am. Assoc. Veterinary Laboratory Diagnosticians, Inc."},{"key":"10.1016\/bs.apar.2025.09.001_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.100995","article-title":"The potential of climatic suitability indicator for Leishmania transmission modelling in Europe: insights and suggested directions","volume":"43","author":"Paz","year":"2024","journal-title":"Lancet Regional Health. Europe"},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib319","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1128\/AAC.02813-15","article-title":"The LABCG2 transporter from the protozoan parasite Leishmania is involved in antimony resistance","volume":"60","author":"Perea","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.apar.2025.09.001_bib320","article-title":"Evasion of the complement system by Leishmania through the uptake of factor H, a complement regulatory protein","volume":"224","author":"Pereira-Filho","year":"2021","journal-title":"Acta Tropica"},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib321","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1128\/AAC.00065-11","article-title":"Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania","volume":"55","author":"P\u00e9rez-Victoria","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"50","key":"10.1016\/bs.apar.2025.09.001_bib322","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance","volume":"278","author":"P\u00e9rez-Victoria","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib323","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.45.9.2468-2474.2001","article-title":"Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator","volume":"45","author":"P\u00e9rez-Victoria","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib324","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/acs.jproteome.6b00655","article-title":"Post-translational modifications of trypanosoma cruzi canonical and variant histones","volume":"16","author":"Picchi","year":"2017","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib325","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab065","article-title":"Efficacy and safety of pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review","volume":"28","author":"Piccica","year":"2021","journal-title":"J. Travel. Med."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib326","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1208\/s12249-019-1323-1","article-title":"Amphotericin B-loaded emulgel: effect of chemical enhancers on the release profile and antileishmanial activity in vitro","volume":"20","author":"Pinheiro","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/bs.apar.2025.09.001_bib327","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2334-6-177","article-title":"Leishmania infantum leishmaniasis in corticosteroid \u2013 treated patients","volume":"6","author":"Pittalis","year":"2006","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib328","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molbiopara.2015.07.003","article-title":"Generation of an aquaglyceroporin AQP1 null mutant in Leishmania major","volume":"201","author":"Plourde","year":"2015","journal-title":"Mol. Biochem.\u00a0Parasitol."},{"key":"10.1016\/bs.apar.2025.09.001_bib329","article-title":"Efficacy and safety of paromomycin for visceral leishmaniasis: a systematic review","volume":"2021","author":"Pokharel","year":"2021","journal-title":"J. Trop.\u00a0Med."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib330","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib331","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpddr.2023.09.001","article-title":"Increased copy number of the target gene squalene monooxygenase as the main resistance mechanism to terbinafine in Leishmania infantum","volume":"23","author":"Potvin","year":"2023","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib332","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1093\/cid\/ciaa1236","article-title":"Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite Leishmania donovani","volume":"72","author":"Potvin","year":"2021","journal-title":"Clin. Infect. Dis.: An. Off. Publ. Infect. Diseases Soc. Am."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib333","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007052","article-title":"Genomic instability at the locus of sterol C24-methyltransferase promotes amphotericin B resistance in Leishmania parasites","volume":"13","author":"Pountain","year":"2019","journal-title":"PLoS Neglected Tropical Dis."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib334","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.48.7.2409-2414.2004","article-title":"Cloning of S-adenosyl-L-methionine:C-24-Delta-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-Resistant promastigotes","volume":"48","author":"Pourshafie","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib335","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12835","article-title":"Linking membrane fluidity with defective antigen presentation in leishmaniasis","volume":"43","author":"Pradhan","year":"2021","journal-title":"Parasite Immunol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib336","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.2012.12-0022","article-title":"In vitro antileishmanial drug susceptibility of clinical isolates from patients with Indian visceral leishmaniasis--status of newly introduced drugs","volume":"87","author":"Prajapati","year":"2012","journal-title":"Am. J. Tropical Med. Hyg."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib337","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cid\/ciw662","article-title":"Fluconazole in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis: a randomized controlled trial","volume":"64","author":"Prates","year":"2017","journal-title":"Clin. Infect. Dis.: An. Off. Publ. Infect. Diseases Soc. Am."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib338","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/jac\/dku534","article-title":"Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"70","author":"Purkait","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib339","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib340","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00477-24","article-title":"CRISPR-Cas9 high-throughput screening to study drug resistance in Leishmania infantum","volume":"15","author":"Queffeulou","year":"2024","journal-title":"mBio"},{"key":"10.1016\/bs.apar.2025.09.001_bib341","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejmech.2017.08.030","article-title":"Eugenol derived immunomodulatory molecules against visceral leishmaniasis","volume":"139","author":"Raja","year":"2017","journal-title":"Eur. J. Med.\u00a0Chem"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib342","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/AAC.01123-06","article-title":"Miltefosine affects lipid metabolism in Leishmania donovani promastigotes","volume":"51","author":"Rakotomanga","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib343","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/AAC.49.7.2677-2686.2005","article-title":"Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions","volume":"49","author":"Rakotomanga","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.apar.2025.09.001_bib344","article-title":"Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial","volume":"113","author":"Ramalho","year":"2018","journal-title":"Mem\u00f3rias do Inst. Oswaldo Cruz"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib345","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijpddr.2018.04.002","article-title":"Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs","volume":"8","author":"Rastrojo","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib346","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pt.2010.04.005","article-title":"Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis","volume":"26","author":"Reis","year":"2010","journal-title":"Trends Parasitol."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib347","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1389202918666170911161311","article-title":"Gene and chromosomal copy number variations as an adaptive mechanism towards a parasitic lifestyle in trypanosomatids","volume":"19","author":"Reis-Cunha","year":"2018","journal-title":"Curr. Genomics"},{"issue":"15","key":"10.1016\/bs.apar.2025.09.001_bib348","doi-asserted-by":"crossref","first-page":"9717","DOI":"10.1093\/nar\/gku714","article-title":"Regulation of transcription termination by glucosylated hydroxymethyluracil, base J, in Leishmania major and Trypanosoma brucei","volume":"42","author":"Reynolds","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib349","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/1389557511313050010","article-title":"Quinolines as chemotherapeutic agents for leishmaniasis","volume":"13","author":"Reynolds","year":"2013","journal-title":"Mini Rev. Med.\u00a0Chem"},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib350","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis.: An. Off. Publ. Infect. Dis.\u00a0Soc. Am."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib351","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection","volume":"43","author":"Ritmeijer","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib352","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/cid\/cir674","article-title":"Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence","volume":"53","author":"Ritmeijer","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"21","key":"10.1016\/bs.apar.2025.09.001_bib353","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib354","article-title":"Control of visceral leishmaniasis in Latin America\u2014A systematic review","volume":"4","author":"Romero","year":"2010","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib355","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1382996","article-title":"From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization","volume":"12","author":"Rooholamini","year":"2024","journal-title":"Front. Public. Health"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib356","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313167","article-title":"Clinical, histopathological and parasitological follow-up of dogs naturally infected by Leishmania infantum before and after miltefosine treatment and associated therapies","volume":"20","author":"Rosar","year":"2025","journal-title":"PLOS ONE"},{"key":"10.1016\/bs.apar.2025.09.001_bib357","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2020.107948","article-title":"Immunomodulator mediated changes in plasma membrane calcium ATPase in controlling visceral leishmaniasis","volume":"217","author":"Roy","year":"2020","journal-title":"Exp. Parasitol."},{"key":"10.1016\/bs.apar.2025.09.001_bib358","article-title":"Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56\/ARM58 transcripts and reduced drug uptake","volume":"114","author":"Rugani","year":"2019","journal-title":"Mem. Do Inst. Oswaldo Cruz"},{"key":"10.1016\/bs.apar.2025.09.001_bib359","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biopha.2018.09.149","article-title":"Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: antimony resistance in human isolates from atypical lesions","volume":"108","author":"Rugani","year":"2018","journal-title":"Biomed.\u00a0& Pharmacother. = Biomed. & Pharmacother."},{"key":"10.1016\/bs.apar.2025.09.001_bib360","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2022.108340","article-title":"Leishmania RNA virus 2 (LRV2) exacerbates dermal lesions caused by Leishmania major and comparatively unresponsive to meglumine antimoniate treatment","volume":"241","author":"Saberi","year":"2022","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib361","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes10020010","article-title":"In-depth quantitative proteomics characterization of in vitro selected miltefosine resistance in Leishmania infantum","volume":"10","author":"Saboia-Vahia","year":"2022","journal-title":"Proteomes"},{"key":"10.1016\/bs.apar.2025.09.001_bib362","first-page":"399","article-title":"Leishmania vaccine development: a comprehensive review","author":"Saini","year":"2024","journal-title":"Cell Immunol."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib363","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pt.2024.02.002","article-title":"A promising pipeline of preclinical drug candidates for leishmaniasis and chronic Chagas\u2019 disease","volume":"40","author":"Saldivia","year":"2024","journal-title":"Trends Parasitol."},{"issue":"12","key":"10.1016\/bs.apar.2025.09.001_bib364","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3390\/nano9121749","article-title":"Applications of nanomaterials in leishmaniasis: a focus on recent advances and challenges","volume":"9","author":"Saleem","year":"2019","journal-title":"Nanomaterials"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib365","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4269\/ajtmh.1996.54.425","article-title":"Leishmania RNA viruses in Leishmania of the Viannia subgenus","volume":"54","author":"Salinas","year":"1996","journal-title":"Am. J. Trop.\u00a0Med. Hyg."},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib366","article-title":"Expanded genome-wide comparisons give novel insights into population structure and genetic heterogeneity of Leishmania tropica complex","volume":"14","author":"Salloum","year":"2020","journal-title":"PLoS Negl. Trop.\u00a0Dis."},{"issue":"Pt 9","key":"10.1016\/bs.apar.2025.09.001_bib367","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1017\/S0031182007002569","article-title":"Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani","volume":"134","author":"Samant","year":"2007","journal-title":"Parasitology"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib368","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1186\/s12864-018-5271-z","article-title":"Genomic insights into virulence mechanisms of Leishmania donovani: evidence from an atypical strain","volume":"19","author":"Samarasinghe","year":"2018","journal-title":"BMC Genomics"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib369","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/AAC.01694-08","article-title":"Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug","volume":"53","author":"S\u00e1nchez-Ca\u00f1ete","year":"2009","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"key":"10.1016\/bs.apar.2025.09.001_bib370","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.826287","article-title":"Impact of genetic diversity and genome plasticity of Leishmania spp. in treatment and the search for novel chemotherapeutic targets","volume":"12","author":"Santi","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib371","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13071-021-04838-8","article-title":"Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility","volume":"14","author":"Santi","year":"2021","journal-title":"Parasites & Vectors"},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib372","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/tropicalmed8090430","article-title":"Systematic review of treatment failure and clinical relapses in leishmaniasis from a multifactorial perspective: clinical aspects, factors associated with the parasite and host","volume":"8","author":"Santos","year":"2023","journal-title":"Trop.\u00a0Med. Infect. Dis."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib373","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/AAC.01881-13","article-title":"Reduced antimony accumulation in ARM58-overexpressing Leishmania infantum","volume":"58","author":"Sch\u00e4fer","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib374","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-01658-5","article-title":"Colonization and genetic diversification processes of Leishmania infantum in the Americas","volume":"4","author":"Schwabl","year":"2021","journal-title":"Commun. Biol"},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib375","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1128\/AAC.02406-13","article-title":"Transmission potential of antimony-resistant leishmania field isolates","volume":"58","author":"Seblova","year":"2014","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"key":"10.1016\/bs.apar.2025.09.001_bib376","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.vetpar.2017.04.014","article-title":"Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis","volume":"239","author":"Segarra","year":"2017","journal-title":"Vet.\u00a0Parasitol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib377","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jac\/dkq542","article-title":"In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani","volume":"66","author":"Seifert","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib378","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-024-01032-6","article-title":"Downregulation of IRF7-mediated type-I interferon response by LmCen\u2013\/\u2013 parasites is necessary for protective immunity","volume":"9","author":"Sepahpour","year":"2024","journal-title":"npj Vaccines"},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib379","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.pt.2021.07.003","article-title":"Leishmaniasis: the act of transmission","volume":"37","author":"Serafim","year":"2021","journal-title":"Trends Parasitol."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib380","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1074\/jbc.M005423200","article-title":"Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani","volume":"276","author":"Shaked-Mishan","year":"2001","journal-title":"J. Biol. Chem"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib381","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41467-017-01664-4","article-title":"Atomic resolution snapshot of Leishmania ribosome inhibition by the aminoglycoside paromomycin","volume":"8","author":"Shalev-Benami","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.apar.2025.09.001_bib382","first-page":"90","article-title":"Guidelines for cryotherapy","volume":"75","author":"Sharma","year":"2009","journal-title":"Indian. J. Dermatol., Venereol.\u00a0Leprol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib383","article-title":"Genomic and metabolomic polymorphism among experimentally selected paromomycin-resistant Leishmania donovani strains","volume":"64","author":"Shaw","year":"2019","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib384","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/mmi.13291","article-title":"In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization","volume":"99","author":"Shaw","year":"2016","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib385","article-title":"Host cell signalling and leishmania mechanisms of evasion","author":"Shio","year":"2012","journal-title":"J. Trop.\u00a0Med. 2012"},{"key":"10.1016\/bs.apar.2025.09.001_bib386","first-page":"11","article-title":"Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis","volume":"10","author":"Shirzadi","year":"2019","journal-title":"Res. Rep. Trop.\u00a0Med."},{"issue":"15","key":"10.1016\/bs.apar.2025.09.001_bib387","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.molimm.2011.05.013","article-title":"Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression","volume":"48","author":"Shweash","year":"2011","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib388","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259009","article-title":"Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: a challenge to infection control and disease elimination","volume":"16","author":"Silva","year":"2021","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib389","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1399-3062.2011.00598.x","article-title":"Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature","volume":"13","author":"Simon","year":"2011","journal-title":"Transpl. Infect. Dis."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib390","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/expr.2001.4663","article-title":"Gene amplification in amphotericin B-resistant Leishmania tarentolae","volume":"99","author":"Singh","year":"2001","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib391","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.actatropica.2007.06.004","article-title":"Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani","volume":"103","author":"Singh","year":"2007","journal-title":"Acta Tropica"},{"key":"10.1016\/bs.apar.2025.09.001_bib392","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.redox.2017.03.004","article-title":"Deciphering the interplay between cysteine synthase and thiol cascade proteins in modulating Amphotericin B resistance and survival of Leishmania donovani under oxidative stress","volume":"12","author":"Singh","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/bs.apar.2025.09.001_bib393","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s13071-014-0596-1","article-title":"The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India","volume":"7","author":"Singh","year":"2014","journal-title":"Parasites & Vectors"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib394","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijantimicag.2010.03.012","article-title":"Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites","volume":"36","author":"Singh","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib395","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/acsinfecdis.4c00693","article-title":"Advancing treatment for leishmaniasis: from overcoming challenges to embracing therapeutic innovations","volume":"11","author":"Singh","year":"2025","journal-title":"ACS Infect. Dis."},{"issue":"27","key":"10.1016\/bs.apar.2025.09.001_bib396","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL\u00ae adjuvant","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/bs.apar.2025.09.001_bib397","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1471-2164-10-240","article-title":"Organization and evolution of two SIDER retroposon subfamilies and their impact on the Leishmania genome","volume":"10","author":"Smith","year":"2009","journal-title":"BMC Genomics"},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib398","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00001813-200011000-00006","article-title":"Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients","volume":"11","author":"Smorenburg","year":"2000","journal-title":"Anti-Cancer Drugs"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib399","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-3305-4-86","article-title":"LeishVet guidelines for the practical management of canine leishmaniosis","volume":"4","author":"Solano-Gallego","year":"2011","journal-title":"Parasites & Vectors"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib400","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11686-021-00463-8","article-title":"Mitogen-activated protein kinase and aquaglyceroporin gene expression in treatment failure Leishmania major","volume":"67","author":"Somee","year":"2022","journal-title":"Acta Parasitol."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib401","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4269\/ajtmh.12-0736","article-title":"Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama","volume":"89","author":"Sosa","year":"2013","journal-title":"Am. J. Trop.\u00a0Med. Hyg."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib402","article-title":"Topical paromomycin for New World cutaneous leishmaniasis","volume":"13","author":"Sosa","year":"2019","journal-title":"PLoS Negl. Trop.\u00a0Dis."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib403","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4269\/ajtmh.15-0640","article-title":"Intralesional pentamidine: a novel therapy for single lesions of bolivian cutaneous leishmaniasis","volume":"94","author":"Soto","year":"2016","journal-title":"Am. J. Trop.\u00a0Med. Hyg."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib404","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13071-017-1969-z","article-title":"Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India","volume":"10","author":"Srivastava","year":"2017","journal-title":"Parasites & Vectors"},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib405","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cei.12074","article-title":"Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses","volume":"172","author":"Srivastava","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib406","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1128\/JCM.00173-11","article-title":"Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic","volume":"49","author":"Srivastava","year":"2011","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib407","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.pt.2014.07.002","article-title":"Parasexuality and mosaic aneuploidy in Leishmania: alternative genetics","volume":"30","author":"Sterkers","year":"2014","journal-title":"Trends Parasitol."},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib408","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Tropical Med. & Int. health: TM. & IH"},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib409","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"Sundar","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib410","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/13543784.2014.954035","article-title":"Investigational drugs for visceral leishmaniasis","volume":"24","author":"Sundar","year":"2015","journal-title":"Expert. Opin. Investig.\u00a0Drugs"},{"key":"10.1016\/bs.apar.2025.09.001_bib411","series-title":"Expert Opinion on Orphan Drugs","article-title":"Leishmaniasis: treatment, drug resistance and emerging therapies","author":"Sundar","year":"2019"},{"issue":"22","key":"10.1016\/bs.apar.2025.09.001_bib412","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/bs.apar.2025.09.001_bib413","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for Visceral leishmaniasis in India","volume":"356","author":"Sundar","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.apar.2025.09.001_bib414","series-title":"Expert Opinion on Orphan Drugs","first-page":"19","article-title":"Current and emerging therapies for the treatment of leishmaniasis","author":"Sundar","year":"2024"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib415","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2021.100487","article-title":"Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV","volume":"3","author":"Takele","year":"2022","journal-title":"Cell Reports. Med."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib416","article-title":"Extracellular vesicles: translational agenda questions for three protozoan parasites","volume":"25","author":"Tandoh","year":"2024","journal-title":"Traffic (Copenhagen, Den.)"},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib417","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1128\/AAC.01847-13","article-title":"Characterization of the proliferating cell nuclear antigen of Leishmania donovani clinical isolates and its association with antimony resistance","volume":"58","author":"Tandon","year":"2014","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"issue":"24","key":"10.1016\/bs.apar.2025.09.001_bib418","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1073\/pnas.85.24.9572","article-title":"LR1: a candidate RNA virus of Leishmania","volume":"85","author":"Tarr","year":"1988","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib419","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1128\/AAC.00544-16","article-title":"A telomeric cluster of antimony resistance genes on chromosome 34 of Leishmania infantum","volume":"60","author":"Tejera Nevado","year":"2016","journal-title":"Antimicrob.\u00a0Agents Chemother."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib420","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4269\/ajtmh.16-0983","article-title":"Identification and functional validation of a biomarker for the diagnosis of miltefosine relapse during visceral leishmaniasis","volume":"98","author":"Tiwary","year":"2018","journal-title":"Am. J. Trop.\u00a0Med. Hyg."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib421","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13071-019-3312-3","article-title":"Comorbid infections induce progression of visceral leishmaniasis","volume":"12","author":"Toepp","year":"2019","journal-title":"Parasites & Vectors"},{"key":"10.1016\/bs.apar.2025.09.001_bib422","doi-asserted-by":"crossref","first-page":"750","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib423","article-title":"Canine visceral leishmaniasis: diagnosis and management of the reservoir living among us","volume":"12","author":"Travi","year":"2018","journal-title":"PLoS Negl.\u00a0Trop. Dis."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib424","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijpddr.2018.10.007","article-title":"Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania","volume":"8","author":"Trinconi","year":"2018","journal-title":"Int. J. Parasitol.\u00a0Drugs Drug. Resist."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib425","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jac\/dkv495","article-title":"Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis","volume":"71","author":"Trinconi","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib426","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012382","article-title":"Sterol 14-alpha demethylase (CYP51) activity in Leishmania donovani is likely dependent upon cytochrome P450 reductase 1","volume":"20","author":"Tulloch","year":"2024","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib427","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/acsinfecdis.9b00505","article-title":"Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors","volume":"6","author":"Tunes","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib428","article-title":"Fitness and phenotypic characterization of miltefosine-resistant Leishmania major","volume":"9","author":"Turner","year":"2015","journal-title":"PLoS Negl.\u00a0Trop.\u00a0Dis."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib429","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2008-9-7-r115","article-title":"Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy","volume":"9","author":"Ubeda","year":"2008","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001868","article-title":"Genome-wide stochastic adaptive DNA amplification at direct and inverted DNA repeats in the parasite Leishmania","volume":"12","author":"Ubeda","year":"2014","journal-title":"PLoS Biol."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib431","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S0031182016002523","article-title":"Chemotherapy of leishmaniasis: present challenges","volume":"145","author":"Uliana","year":"2018","journal-title":"Parasitology"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib432","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10103-024-04174-0","article-title":"Photodynamic therapy in management of cutaneous leishmaniasis: a systematic review","volume":"39","author":"Ullah","year":"2024","journal-title":"Lasers Med. Sci."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib433","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1645\/GE-185R","article-title":"Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey","volume":"90","author":"Uzun","year":"2004","journal-title":"J. Parasitol."},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib434","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/biom9110723","article-title":"The Novel Serine\/Threonine protein kinase LmjF.22.0810 from Leishmania major may be involved in the resistance to drugs such as paromomycin","volume":"9","author":"Vacas","year":"2019","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib435","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/biomedicines8110452","article-title":"LmjF.22.0810 from Leishmania major modulates the Th2-type immune response and is involved in leishmaniasis outcome","volume":"8","author":"Vacas","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib436","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s13071-016-1904-8","article-title":"A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani","volume":"9","author":"Vacchina","year":"2016","journal-title":"Parasites & Vectors"},{"key":"10.1016\/bs.apar.2025.09.001_bib437","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107190","article-title":"Insights into the trypanothione system in antimony-resistant and sensitive Leishmania tropica clinical isolates","volume":"254","author":"Valashani","year":"2024","journal-title":"Acta Tropica"},{"key":"10.1016\/bs.apar.2025.09.001_bib438","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpddr.2020.04.004","article-title":"Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection","volume":"13","author":"Van Bockstal","year":"2020","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"key":"10.1016\/bs.apar.2025.09.001_bib439","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpddr.2019.09.003","article-title":"Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis","volume":"11","author":"Van Bockstal","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib440","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1016\/S1473-3099(23)00353-5","article-title":"The status of combination therapy for visceral leishmaniasis: an updated review","volume":"24","author":"van Griensven","year":"2024","journal-title":"Lancet. Infect. Dis."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib441","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/1040841X.2012.716818","article-title":"Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?","volume":"39","author":"Vanaerschot","year":"2013","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/bs.apar.2025.09.001_bib442","article-title":"Photodynamic therapy for leishmaniasis: recent advances and future trends","volume":"36","author":"Varzandeh","year":"2021","journal-title":"Photodiagnosis Photodyn.\u00a0Ther."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib443","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/tmi.13382","article-title":"Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy","volume":"25","author":"Velez","year":"2020","journal-title":"Trop.\u00a0Med. & Int. Health"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib444","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1074\/mcp.M600319-MCP200","article-title":"A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death","volume":"6","author":"Vergnes","year":"2007","journal-title":"Mol. & Cell. Proteomics: MCP"},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib445","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijpddr.2017.10.004","article-title":"Transcriptome profiling identifies genes\/pathways associated with experimental resistance to paromomycin in Leishmania donovani","volume":"7","author":"Verma","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"issue":"8","key":"10.1016\/bs.apar.2025.09.001_bib446","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1128\/AAC.48.8.3010-3015.2004","article-title":"Possible mechanism of miltefosine-mediated death of Leishmania donovani","volume":"48","author":"Verma","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"17","key":"10.1016\/bs.apar.2025.09.001_bib447","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1111\/febs.14923","article-title":"Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani","volume":"286","author":"Veronica","year":"2019","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib448","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/pathogens11040431","article-title":"The history of live attenuated centrin gene-deleted Leishmania vaccine candidates","volume":"11","author":"Volpedo","year":"2022","journal-title":"Pathogens"},{"issue":"9","key":"10.1016\/bs.apar.2025.09.001_bib449","first-page":"963","article-title":"Leishmania infantum infection in a dog imported from Morocco","volume":"61","author":"Wagner","year":"2020","journal-title":"Can. Veterinary J. = La. Rev. Veterinaire Canadienne"},{"issue":"14","key":"10.1016\/bs.apar.2025.09.001_bib450","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2174\/1381612825666190621154552","article-title":"Innovative solutions for the control of leishmaniases: nanoscale drug delivery systems","volume":"25","author":"Wagner","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib451","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.molbiopara.2012.03.002","article-title":"Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis","volume":"183","author":"Walker","year":"2012","journal-title":"Mol. Biochem.\u00a0Parasitol."},{"issue":"5","key":"10.1016\/bs.apar.2025.09.001_bib452","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1645\/GE-3347","article-title":"Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents","volume":"90","author":"Walker","year":"2004","journal-title":"J. Parasitol."},{"issue":"6","key":"10.1016\/bs.apar.2025.09.001_bib453","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/trstmh\/trw031","article-title":"The leishmaniasis East Africa platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis","volume":"110","author":"Wasunna","year":"2016","journal-title":"Trans. R. Soc. Trop.\u00a0Med. Hyg."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib454","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12416","article-title":"MISEV2023: An updated guide to EV research and applications","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/bs.apar.2025.09.001_bib455","article-title":"Tackling drug resistance and other causes of treatment failure in leishmaniasis","volume":"3","author":"Wijnant","year":"2022","journal-title":"Front. Trop.\u00a0Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib456","unstructured":"World Health Organization, 1995. Epidemiological analysis of 692 retrospective cases of leishmania\/HIV co-infections. Available at: https:\/\/www.who.int\/publications\/i\/item\/WHO-LEISH-96.39 (Accessed 9 April 2025)."},{"key":"10.1016\/bs.apar.2025.09.001_bib457","unstructured":"World Health Organization, 2023.\u00a0Leishmaniasis. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis (Accessed 4 April 2025)."},{"key":"10.1016\/bs.apar.2025.09.001_bib458","unstructured":"World Health Organization, 2024a.\u00a0Fact sheets - Malnutrition. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malnutrition (Accessed 9 April 2025)."},{"key":"10.1016\/bs.apar.2025.09.001_bib459","unstructured":"World Health Organization, 2024b. HIV and AIDS. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids (Accessed 9 April 2025)."},{"issue":"2","key":"10.1016\/bs.apar.2025.09.001_bib460","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbiopara.2010.05.015","article-title":"Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates","volume":"173","author":"Wyllie","year":"2010","journal-title":"Mol. Biochem.\u00a0Parasitol."},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib461","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005971","article-title":"Activation of Bicyclic nitro-drugs by a novel nitroreductase (NTR2) in Leishmania","volume":"12","author":"Wyllie","year":"2016","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/bs.apar.2025.09.001_bib462","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004427","article-title":"Sterol biosynthesis is required for heat resistance but not extracellular survival in leishmania","volume":"10","author":"Xu","year":"2014","journal-title":"PLoS Pathog"},{"issue":"Pt B","key":"10.1016\/bs.apar.2025.09.001_bib463","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.ijbiomac.2020.10.134","article-title":"Leishmania donovani chaperonin TCP1\u03b3 subunit protects miltefosine induced oxidative damage","volume":"165","author":"Yadav","year":"2020","journal-title":"Int. J. Biol. Macromolecules"},{"issue":"11","key":"10.1016\/bs.apar.2025.09.001_bib464","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1128\/AAC.01129-16","article-title":"Antileishmanial mechanism of diamidines involves targeting kinetoplasts","volume":"60","author":"Yang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004341","article-title":"Allopurinol resistance in leishmania infantum from dogs with disease relapse","volume":"10","author":"Yasur-Landau","year":"2016","journal-title":"PLOS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib466","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijpddr.2018.08.002","article-title":"Resistance of Leishmania infantum to allopurinol is associated with chromosome and gene copy number variations including decrease in the S-adenosylmethionine synthetase (METK) gene copy number","volume":"8","author":"Yasur-Landau","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"issue":"7","key":"10.1016\/bs.apar.2025.09.001_bib467","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1469-0691.2011.03674.x","article-title":"Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe","volume":"18","author":"Zanger","year":"2012","journal-title":"Clin. Microbiol.\u00a0Infect."},{"issue":"4","key":"10.1016\/bs.apar.2025.09.001_bib468","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002836","article-title":"Leishmania aethiopica field isolates bearing an endosymbiontic dsRNA virus induce pro-inflammatory cytokine response","volume":"8","author":"Zangger","year":"2014","journal-title":"PLOS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib469","article-title":"Detection of Leishmania RNA virus in Leishmania parasites","volume":"7","author":"Zangger","year":"2013","journal-title":"PLOS Negl.\u00a0Trop. Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib470","doi-asserted-by":"crossref","DOI":"10.1016\/j.parepi.2025.e00413","article-title":"Identification of C\u03b2S and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling","volume":"28","author":"Zarrinkar","year":"2025","journal-title":"Parasite Epidemiol. Control"},{"issue":"1","key":"10.1016\/bs.apar.2025.09.001_bib471","article-title":"Progress in antileishmanial drugs: mechanisms, challenges, and prospects","volume":"19","author":"Zhang","year":"2025","journal-title":"PLoS Negl.\u00a0Trop.\u00a0Dis."},{"key":"10.1016\/bs.apar.2025.09.001_bib472","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1038\/s41467-020-17154-z","article-title":"A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing","author":"Zhang","year":"2020","journal-title":"Nature Commun."},{"issue":"3","key":"10.1016\/bs.apar.2025.09.001_bib473","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/mol.111.072322","article-title":"Miltefosine induces apoptosis-like cell death in yeast via Cox9p in cytochrome c oxidase","volume":"80","author":"Zuo","year":"2011","journal-title":"Mol. Pharmacol."}],"container-title":["Advances in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065308X25000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065308X25000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:39:33Z","timestamp":1762612773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065308X25000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443346415"],"references-count":473,"URL":"https:\/\/doi.org\/10.1016\/bs.apar.2025.09.001","relation":{},"ISSN":["0065-308X"],"issn-type":[{"type":"print","value":"0065-308X"}],"subject":[],"published":{"date-parts":[[2025]]}}}